Case Report
Copyright ©The Author(s) 2023.
World J Clin Cases. Jun 16, 2023; 11(17): 4202-4209
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.4202
Table 2 Crohn’s disease and human immunodeficiency virus treatment (in August)
Inpatient treatment
Crohn’s disease exacerbation treatmentHIV treatment
Prednisolone30 mg × 15 mg/wkEmtricitabine/tenofovir disoproxil200 mg/245 mg × 1
Metronidazole500 mg × 3Dolutegravir50 mg × 1
Mesalazine2000 mg × 2
Azathioprine50 mg × 2
Outpatient treatment
Crohn’s disease treatmentHIV treatment
PrednisoloneEventually discontinuedEmtricitabine/tenofovir disoproxil200 mg/245 mg × 1
Mesalazine2000 mg × 2Dolutegravir50 mg × 1
Azathioprine50 mg × 2